Skip to main content
SpringerLink
Log in

The genetics of cardiomyopathies: What clinicians should know

  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Primary myocardial diseases, or cardiomyopathies, affect millions of individuals worldwide. Although there are sizable environmental contributors to the etiology of these diseases, many cardiomyopathies have a high degree of heritability and, thus, genetic aspects of diagnosis and therapy warrant special consideration. The past two decades have seen enormous progress in elucidating the epidemiology, genetic architecture, and pathophysiology of these diseases. In this review, we focus on translating advances in the genetics of cardiomyopathies to clinical care. We discuss the underlying genetic and phenotypic complexity of these disorders, highlighting the implications for diagnosis, treatment, screening, and prognosis of patients and their family members.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Seidman JG, Seidman C: The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001, 104:557–567.

    Article  PubMed  CAS  Google Scholar 

  2. Maron BJ, Towbin JA, Thiene G, et al.: Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006, 113:1807–1816.

    Article  PubMed  Google Scholar 

  3. Codd MB, Sugrue DD, Gersh BJ, Melton LJ 3rd: Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975–1984. Circulation 1989, 80:564–572.

    PubMed  CAS  Google Scholar 

  4. Nakayama Y, Shimizu G, Hirota Y, et al.: Functional and histopathologic correlation in patients with dilated cardiomyopathy: an integrated evaluation by multivariate analysis. J Am Coll Cardiol 1987, 10:186–192.

    Article  PubMed  CAS  Google Scholar 

  5. Mestroni L, Maisch B, McKenna WJ, et al.: Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J 1999, 20:93–102.

    Article  PubMed  CAS  Google Scholar 

  6. McKenna CJ, Codd MB, McCann HA, Sugrue DD: Idiopathic dilated cardiomyopathy: familial prevalence and HLA distribution. Heart 1997, 77:549–552.

    PubMed  CAS  Google Scholar 

  7. Taylor MR, Slavov D, Ku L, et al.: Prevalence of desmin mutations in dilated cardiomyopathy. Circulation 2007, 115:1244–1251.

    Article  PubMed  CAS  Google Scholar 

  8. Marshall JD, Hinman EG, Collin GB, et al.: Spectrum of ALMS1 variants and evaluation of genotype-phenotype correlations in Alstrom syndrome. Hum Mutat 2007, 28:1114–1123.

    Article  PubMed  CAS  Google Scholar 

  9. Arbustini E, Pilotto A, Repetto A, et al.: Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 2002, 39:981–990.

    Article  PubMed  CAS  Google Scholar 

  10. Meune C, Van Berlo JH, Anselme F, et al.: Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 2006, 354:209–210.

    Article  PubMed  CAS  Google Scholar 

  11. Mahon NG, Murphy RT, MacRae CA, et al.: Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. Ann Intern Med 2005, 143:108–115.

    PubMed  Google Scholar 

  12. Hunt SA: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005, 46:e1–e82.

    Article  PubMed  Google Scholar 

  13. Maron BJ, Gardin JM, Flack JM, et al.: Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995, 92:785–789.

    PubMed  CAS  Google Scholar 

  14. Maron BJ, Spirito P, Roman MJ, et al.: Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study). Am J Cardiol 2004, 93:1510–1514.

    Article  PubMed  Google Scholar 

  15. Maron BJ, Casey SA, Poliac LC, et al.: Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999, 281:650–655.

    Article  PubMed  CAS  Google Scholar 

  16. Maron BJ, Nichols PF 3rd, Pickle LW, et al.: Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol 1984, 53:1087–1094.

    Article  PubMed  CAS  Google Scholar 

  17. Ho CY, Seidman CE: A contemporary approach to hypertrophic cardiomyopathy. Circulation 2006, 113:e858–e862.

    Article  PubMed  Google Scholar 

  18. Ashrafian H, Watkins H: Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype. J Am Coll Cardiol 2007, 49:1251–1264.

    Article  PubMed  CAS  Google Scholar 

  19. Arad M, Maron BJ, Gorham JM, et al.: Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005, 352:362–372.

    Article  PubMed  CAS  Google Scholar 

  20. Richard P, Charron P, Carrier L, et al.: Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003, 107:2227–2232.

    Article  PubMed  Google Scholar 

  21. McMahon CJ, Nagueh SF, Pignatelli RH, et al.: Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy. Circulation 2004, 109:1756–1762.

    Article  PubMed  Google Scholar 

  22. Petersen SE, Jerosch-Herold M, Hudsmith LE, et al.: Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 2007, 115:2418–2425.

    Article  PubMed  Google Scholar 

  23. Maron BJ, Seidman JG, Seidman CE: Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 44:2125–2132.

    Article  PubMed  Google Scholar 

  24. Ackerman MJ, VanDriest SL, Ommen SR, et al.: Prevalence and age-dependence of malignant mutations in the betamyosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. J Am Coll Cardiol 2002, 39:2042–2048.

    Article  PubMed  CAS  Google Scholar 

  25. Moolman JC, Corfield VA, Posen B, et al.: Sudden death due to troponin T mutations. J Am Coll Cardiol 1997, 29:549–555

    Article  PubMed  CAS  Google Scholar 

  26. Elliott PM, Sharma S, Varnava A, et al.: Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999, 33:1596–1601.

    Article  PubMed  CAS  Google Scholar 

  27. Elliott PM, Poloniecki J, Dickie S, et al.: Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000, 36:2212–2218.

    Article  PubMed  CAS  Google Scholar 

  28. Moon JC, McKenna WJ, McCrohon JA, et al.: Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003, 41:1561–1567.

    Article  PubMed  Google Scholar 

  29. Peters S, Trummel M, Meyners W: Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital. Int J Cardiol 2004, 97:499–501.

    Article  PubMed  Google Scholar 

  30. Dalal D, Nasir K, Bomma C, et al.: Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation 2005, 112:3823–3832.

    Article  PubMed  Google Scholar 

  31. Calkins H: Arrhythmogenic right-ventricular dysplasia/cardiomyopathy. Curr Opin Cardiol 2006, 21:55–63.

    Article  PubMed  Google Scholar 

  32. McKenna WJ, Thiene G, Nava A, et al.: Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994, 71:215–218.

    Article  PubMed  CAS  Google Scholar 

  33. Hamid MS, Norman M, Quraishi A, et al.: Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002, 40:1445–1450.

    Article  PubMed  Google Scholar 

  34. van Tintelen JP, Hofstra RM, Wiesfeld AC, et al.: Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon? Curr Opin Cardiol 2007, 22:185–192.

    Article  PubMed  Google Scholar 

  35. Dalal D, James C, Devanagondi R, et al.: Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2006, 48:1416–1424.

    Article  PubMed  CAS  Google Scholar 

  36. van Tintelen JP, Entius MM, Bhuiyan ZA, et al.: Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2006, 113:1650–1658.

    Article  PubMed  CAS  Google Scholar 

  37. Kies P, Bootsma M, Bax JJ, et al.: Serial reevaluation for ARVD/C is indicated in patients presenting with left bundle branch block ventricular tachycardia and minor ECG abnormalities. J Cardiovasc Electrophysiol 2006, 17:586–593.

    Article  PubMed  Google Scholar 

  38. Wichter T, Breithardt G: Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making? J Am Coll Cardiol 2005, 45:409–411.

    Article  PubMed  Google Scholar 

  39. Bauce B, Basso C, Rampazzo A, et al.: Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J 2005, 26:1666–1675.

    Article  PubMed  CAS  Google Scholar 

  40. Hodgkinson KA, Parfrey PS, Bassett AS, et al.: The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol 2005, 45:400–408.

    Article  PubMed  Google Scholar 

  41. Dalal D, Molin LH, Piccini J, et al.: Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation 2006, 113:1641–1649.

    Article  PubMed  CAS  Google Scholar 

  42. Syrris P, Ward D, Asimaki A, et al.: Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy. Circulation 2006, 113:356–364.

    Article  PubMed  CAS  Google Scholar 

  43. Piccini JP, Dalal D, Roguin A, et al.: Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2005, 2:1188–1194.

    Article  PubMed  Google Scholar 

  44. Roguin A, Bomma CS, Nasir K, et al.: Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2004, 43:1843–1852.

    Article  PubMed  Google Scholar 

  45. Lemola K, Brunckhorst C, Helfenstein U, et al.: Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre. Heart 2005, 91:1167–1172.

    Article  PubMed  CAS  Google Scholar 

  46. Nava A, Bauce B, Basso C, et al.: Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2000, 36:2226–2233.

    Article  PubMed  CAS  Google Scholar 

  47. Frigo G, Bauce B, Basso C, Nava A: Late-onset arrhythmogenic right ventricular cardiomyopathy. J Cardiovasc Med (Hagerstown) 2006, 7:74–76.

    Article  Google Scholar 

  48. Fitzpatrick AP, Shapiro LM, Rickards AF, Poole-Wilson PA: Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. Br Heart J 1990, 63:114–118.

    Article  PubMed  CAS  Google Scholar 

  49. Angelini A, Calzolari V, Thiene G, et al.: Morphologic spectrum of primary restrictive cardiomyopathy. Am J Cardiol 1997, 80:1046–1050.

    Article  PubMed  CAS  Google Scholar 

  50. Kubo T, Gimeno JR, Bahl A, et al.: Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. J Am Coll Cardiol 2007, 49:2419–2426.

    Article  PubMed  CAS  Google Scholar 

  51. Mogensen J, Kubo T, Duque M, et al.: Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. J Clin Invest 2003, 111:209–216.

    Article  PubMed  CAS  Google Scholar 

  52. Hughes SE, McKenna WJ: New insights into the pathology of inherited cardiomyopathy. Heart 2005, 91:257–264.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Division and Cardiovascular Research Center, Massachusetts General Hospital, Yawkey 5-964, 55 Fruit Street, Boston, MA, 02114, USA

    Calum A. MacRae

Authors
  1. Rahul Deo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Calum A. MacRae
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Calum A. MacRae.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deo, R., MacRae, C.A. The genetics of cardiomyopathies: What clinicians should know. Curr Heart Fail Rep 4, 229–235 (2007). https://doi.org/10.1007/s11897-007-0017-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-007-0017-2

Keywords

Search

Navigation